The University of Southampton
University of Southampton Institutional Repository

Association between PNPLA3 rs738409 polymorphism and decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease

Association between PNPLA3 rs738409 polymorphism and decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease
Association between PNPLA3 rs738409 polymorphism and decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease
Aim Evidence is emerging that PNPLA3 rs738409 polymorphism (the major genetic variant associated with susceptibility to non-alcoholic fatty liver disease [NAFLD]) is associated with chronic kidney disease (CKD) in non-diabetic individuals. Currently, little is known about this association in type 2 diabetic (T2DM) patients with and without NAFLD. Methods We studied 101 Caucasian post-menopausal women with T2DM, consecutively attending our diabetes outpatient service during a 3-month period. Glomerular filtration rate (eGFRCKD-EPI) was estimated using the CKD-Epidemiology Collaboration (CKD-EPI) equation, whilst albuminuria was measured with an immunonephelometric assay on morning spot urine samples. NAFLD was detected either by fatty liver index (FLI ≥ 60, n = 101) or by ultrasonography (n = 77). Genotyping was performed by TaqMan-Based RT-PCR system. Results Eight patients had G/G, 41 G/C and 52 C/C PNPLA3 rs738409 genotypes, and 21 (20.8%) patients had CKD (eGFRCKD-EPI < 60 mL/min/1.73 m2 or abnormal albuminuria). Compared to those with G/C or C/C genotypes, patients with G/G genotype had significantly lower eGFRCKD-EPI (63.7 ± 11 vs. 77.4 ± 17 vs. 81.9 ± 15 mL/min/1.73 m2, P = 0.014) and higher prevalence of CKD (50% vs. 24.4% vs. 13.5%, P = 0.04). After adjustment for age, duration of diabetes, haemoglobin A1c, HOMA-estimated insulin resistance, systolic blood pressure, hypertension treatment and FLI ≥ 60, rs738409 G/G genotype was independently associated with both lower eGFRCKD-EPI (β coefficient: −15.5, 95% CI −26.0 to −5.0, P = 0.004) and higher risk of CKD (adjusted-odds ratio 8.05, 95% CI 1.26–41.4, P = 0.03). Similar results were found when we adjusted for hepatic steatosis on ultrasography (instead of FLI ≥ 60). Conclusion Regardless of the presence of NAFLD and common cardio-renal risk factors, in post-menopausal women with T2DM, the G/G genotype of rs738409 in the PNPLA3 gene was strongly associated with lower eGFRCKD-EPI and higher prevalence of CKD.
1262-3636
480-487
Mantovani, Alessandro
19fc8a1f-60fe-403a-b70e-6b6884929e03
Zusi, Chiara
3e85eaa8-d04a-4e85-82eb-06dd985ec752
Sani, Elena
2fbd833b-e154-46a4-9ca4-70f006091d26
Colecchia, Antonio
9e0e6233-5122-4488-97b6-f5c114491cc3
Lippi, Giuseppe
dbada834-d943-4efe-9b3f-29405aafcbcc
Zaza, Gianluigi
691643f1-934e-4330-8e05-7a62f22c3a0f
Valenti, Luca
2e850d3c-a3c6-49f4-8f5f-b8cec157f07a
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Maffeis, Claudio
3d8fde9e-5734-4b6c-8978-0a76d45709dd
Bonora, Enzo
9749822a-7df5-4a96-a8a7-fa15070aaa1f
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f
Mantovani, Alessandro
19fc8a1f-60fe-403a-b70e-6b6884929e03
Zusi, Chiara
3e85eaa8-d04a-4e85-82eb-06dd985ec752
Sani, Elena
2fbd833b-e154-46a4-9ca4-70f006091d26
Colecchia, Antonio
9e0e6233-5122-4488-97b6-f5c114491cc3
Lippi, Giuseppe
dbada834-d943-4efe-9b3f-29405aafcbcc
Zaza, Gianluigi
691643f1-934e-4330-8e05-7a62f22c3a0f
Valenti, Luca
2e850d3c-a3c6-49f4-8f5f-b8cec157f07a
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Maffeis, Claudio
3d8fde9e-5734-4b6c-8978-0a76d45709dd
Bonora, Enzo
9749822a-7df5-4a96-a8a7-fa15070aaa1f
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f

Mantovani, Alessandro, Zusi, Chiara, Sani, Elena, Colecchia, Antonio, Lippi, Giuseppe, Zaza, Gianluigi, Valenti, Luca, Byrne, Christopher, Maffeis, Claudio, Bonora, Enzo and Targher, Giovanni (2019) Association between PNPLA3 rs738409 polymorphism and decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease. Diabetes & Metabolism, 45 (5), 480-487. (doi:10.1016/j.diabet.2019.01.011).

Record type: Article

Abstract

Aim Evidence is emerging that PNPLA3 rs738409 polymorphism (the major genetic variant associated with susceptibility to non-alcoholic fatty liver disease [NAFLD]) is associated with chronic kidney disease (CKD) in non-diabetic individuals. Currently, little is known about this association in type 2 diabetic (T2DM) patients with and without NAFLD. Methods We studied 101 Caucasian post-menopausal women with T2DM, consecutively attending our diabetes outpatient service during a 3-month period. Glomerular filtration rate (eGFRCKD-EPI) was estimated using the CKD-Epidemiology Collaboration (CKD-EPI) equation, whilst albuminuria was measured with an immunonephelometric assay on morning spot urine samples. NAFLD was detected either by fatty liver index (FLI ≥ 60, n = 101) or by ultrasonography (n = 77). Genotyping was performed by TaqMan-Based RT-PCR system. Results Eight patients had G/G, 41 G/C and 52 C/C PNPLA3 rs738409 genotypes, and 21 (20.8%) patients had CKD (eGFRCKD-EPI < 60 mL/min/1.73 m2 or abnormal albuminuria). Compared to those with G/C or C/C genotypes, patients with G/G genotype had significantly lower eGFRCKD-EPI (63.7 ± 11 vs. 77.4 ± 17 vs. 81.9 ± 15 mL/min/1.73 m2, P = 0.014) and higher prevalence of CKD (50% vs. 24.4% vs. 13.5%, P = 0.04). After adjustment for age, duration of diabetes, haemoglobin A1c, HOMA-estimated insulin resistance, systolic blood pressure, hypertension treatment and FLI ≥ 60, rs738409 G/G genotype was independently associated with both lower eGFRCKD-EPI (β coefficient: −15.5, 95% CI −26.0 to −5.0, P = 0.004) and higher risk of CKD (adjusted-odds ratio 8.05, 95% CI 1.26–41.4, P = 0.03). Similar results were found when we adjusted for hepatic steatosis on ultrasography (instead of FLI ≥ 60). Conclusion Regardless of the presence of NAFLD and common cardio-renal risk factors, in post-menopausal women with T2DM, the G/G genotype of rs738409 in the PNPLA3 gene was strongly associated with lower eGFRCKD-EPI and higher prevalence of CKD.

Text
PNPLA3 and CKD_final_Diabetes and Metabolism_accepted - Accepted Manuscript
Download (275kB)
Text
Figure 1_accepted - Accepted Manuscript
Download (72kB)

More information

Accepted/In Press date: 31 January 2019
e-pub ahead of print date: 11 February 2019
Published date: 1 October 2019

Identifiers

Local EPrints ID: 428101
URI: http://eprints.soton.ac.uk/id/eprint/428101
ISSN: 1262-3636
PURE UUID: 95b85601-c40d-4682-98ef-a5d2de0ff136
ORCID for Christopher Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 11 Feb 2019 17:30
Last modified: 16 Mar 2024 07:34

Export record

Altmetrics

Contributors

Author: Alessandro Mantovani
Author: Chiara Zusi
Author: Elena Sani
Author: Antonio Colecchia
Author: Giuseppe Lippi
Author: Gianluigi Zaza
Author: Luca Valenti
Author: Claudio Maffeis
Author: Enzo Bonora
Author: Giovanni Targher

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×